Flavoxate HCL en es it fr

Flavoxate HCL Brand names, Flavoxate HCL Analogs

Flavoxate HCL Brand Names Mixture

  • No information avaliable

Flavoxate HCL Chemical_Formula


Flavoxate HCL RX_link

No information avaliable

Flavoxate HCL fda sheet

Flavoxate HCL msds (material safety sheet)

Flavoxate HCL Synthesis Reference

No information avaliable

Flavoxate HCL Molecular Weight

1140.24 g/mol

Flavoxate HCL Melting Point

No information avaliable

Flavoxate HCL H2O Solubility

Practically insoluble

Flavoxate HCL State


Flavoxate HCL LogP


Flavoxate HCL Dosage Forms

Injection (50 mg vials to be reconstituted prior to injection)

Flavoxate HCL Indication

For use in the treatment of the following fungal infections: Candidemia and other forms of Candida infections (intra-abdominal abscess, and peritonitis) and esophageal candidiasis.

Flavoxate HCL Pharmacology

Anidulafungin is a semi-synthetic lipopeptide synthesized from a fermentation product of Aspergillus nidulans. Anidulafungin is an echinocandin, a class of antifungal drugs that inhibits the synthesis of 1,3-β-D-glucan, an essential component of fungal cell walls. Anidulafungin is active in vitro against Candida albicans, C. glabrata, C. parapsilosis, and C. tropicalis.

Flavoxate HCL Absorption

No information avaliable

Flavoxate HCL side effects and Toxicity

During clinical trials a single 400 mg dose of anidulafungin was inadvertently administered as a loading dose. No clinical adverse events were reported. The maximum non-lethal dose of anidulafungin in rats was 50 mg/kg, a dose which is equivalent to 10 times the recommended daily dose for esophageal candidiasis (50mg/day).

Flavoxate HCL Patient Information

Flavoxate HCL Organisms Affected

Aspergillis, Candida and other fungi